Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
Cochrane Database of Systematic Reviews2007Vol. 2010(1), pp. CD004996–CD004996
Citations Over TimeTop 10% of 2007 papers
Abstract
There is insufficient data to either support or refute the use of antioxidant supplements for patients with NAFLD. It may be advisable to carry out large prospective randomised clinical trials on this topic.
Related Papers
- → Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease(2008)250 cited
- → Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?(2012)215 cited
- → Are Steatosis and Steatohepatitis Triggers of Hepatic Fibrogenesis(2013)2 cited
- → Faculty Opinions recommendation of Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis.(2008)
- → STUDY OF CELL MODELS OF HEPG2 STEATOSIS AND STEATOHEPATITIS VIABILITY(2023)